1 citations
,
October 2022 in “Current Opinion in Endocrinology, Diabetes and Obesity” Female pattern hair loss is common in women with polycystic ovarian syndrome.
1 citations
,
October 2021 in “QJM: An International Journal of Medicine” Double-spin PRP is more effective for treating female hair loss than single-spin PRP.
1 citations
,
January 2021 in “Menoufia Medical Journal” Alopecia areata may be linked to heart issues.
1 citations
,
December 2019 in “Journal of skin and stem cell” PRP shows promise for short-term hair growth, especially in young men.
1 citations
,
August 2018 in “Journal of The American Academy of Dermatology” Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.
1 citations
,
July 2016 in “PubMed” Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.
May 2026 in “Journal of Drugs in Dermatology” The dual-serum cosmetic system effectively improves hair loss in women.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The study provides exploratory findings on miRNA changes in female hair loss.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The study explores miRNA changes in female hair loss.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The package offers tools for exploring potential miRNA changes in female hair loss.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The study explores miRNA changes in female hair loss.
April 2026 in “Journal of Dermatological Treatment” CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.
PRP may help with female hair loss short-term, but more research is needed for best results.
January 2026 in “Dermatologic Therapy” Combining microneedling with 5% minoxidil is a safe and effective treatment for female pattern hair loss, promoting significant hair regrowth.
December 2025 in “Journal of Investigative Dermatology” Immune system issues may contribute to female pattern hair loss.
December 2025 in “Lasers in Medical Science” Combining red laser therapy with minoxidil improves hair growth more effectively than minoxidil alone in women with hair loss.
September 2025 in “Romanian Journal of Medical Practice” Iron deficiency is linked to female pattern hair loss.
September 2025 in “Journal of the American Academy of Dermatology” Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.
August 2025 in “Journal of Investigative Dermatology” Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.
May 2025 in “Journal of Investigative Medicine” FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.
May 2025 in “Journal of the American Academy of Dermatology” Oral and topical anti-androgens can help treat female hair loss, but have side effects.
May 2025 in “Egyptian Journal of Dermatology and Venerology” Certain gene changes and hormone levels are linked to female hair loss.
May 2025 in “International Journal of Trichology” Trichoscopic evaluation is important for assessing hair loss in women.
Certain combination therapies, like microneedling with minoxidil, are more effective for female-pattern hair loss than other treatments.
November 2024 in “Journal of Investigative Dermatology” Changes in scalp bacteria are linked to female hair loss, suggesting new treatment options.
September 2024 in “Indian Journal of Dermatology Venereology and Leprology” Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
August 2024 in “IAHS Medical Journal” Low vitamin D and ferritin levels are linked to female hair loss.
June 2024 in “Archives of dermatological research” Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.
May 2024 in “Australasian journal of dermatology” Bicalutamide is more effective and safer than spironolactone for treating female hair loss.
May 2024 in “Dermatologic surgery” Nonactivated low leukocyte PRP injections can significantly increase hair and follicle density in women with alopecia.